within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L04A_Immunosuppressants.L04AE04_Ponesimod;

model Ponesimod
  extends Pharmacolibrary.Drugs.ATC.L.L04AE04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L04AE04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ponesimod is a selective sphingosine 1-phosphate receptor-1 (S1P1) modulator approved for the treatment of relapsing forms of multiple sclerosis (MS) in adults. It reduces lymphocyte egress from lymph nodes, thereby decreasing inflammatory activity in MS.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported in healthy adult subjects after single oral doses.</p><h4>References</h4><ol><li><p>Kruger, TM, et al., &amp; Ruixo, JJP (2023). Clinical Pharmacokinetics of Ponesimod, a Selective S1P1 Receptor Modulator, in the Treatment of Multiple Sclerosis. <i>Clinical pharmacokinetics</i> 62(11) 1533–1550. DOI:<a href=\"https://doi.org/10.1007/s40262-023-01308-5\">10.1007/s40262-023-01308-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37776485/\">https://pubmed.ncbi.nlm.nih.gov/37776485</a></p></li><li><p>Brossard, P, et al., &amp; Dingemanse, J (2013). Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first-in-human study. <i>British journal of clinical pharmacology</i> 76(6) 888–896. DOI:<a href=\"https://doi.org/10.1111/bcp.12129\">10.1111/bcp.12129</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23594176/\">https://pubmed.ncbi.nlm.nih.gov/23594176</a></p></li><li><p>Baldin, E, &amp; Lugaresi, A (2020). Ponesimod for the treatment of relapsing multiple sclerosis. <i>Expert opinion on pharmacotherapy</i> 21(16) 1955–1964. DOI:<a href=\"https://doi.org/10.1080/14656566.2020.1799977\">10.1080/14656566.2020.1799977</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32808832/\">https://pubmed.ncbi.nlm.nih.gov/32808832</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Ponesimod;
